PLIANT THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
PLIANT THERAPEUTICS, INC. (PLRX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$149.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-11
- PLIANT THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$149.30M.
- PLIANT THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$210.30M.
- PLIANT THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$161.30M.
- PLIANT THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$123.30M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$149.30M 10-K · filed 2026-03-11 | |
| 2024-12-31 | -$210.30M 10-K · filed 2026-03-11 | |
| 2023-12-31 | -$161.30M 10-K · filed 2025-03-03 | -$161.34M 10-K · filed 2024-02-27 |
| 2022-12-31 | -$123.30M 10-K · filed 2025-03-03 | |
| 2021-12-31 | -$97.30M 10-K · filed 2024-02-27 | |
| 2020-12-31 | $41.50M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $600.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |